Table 2.
Effects of T2DM on the immune system.
Total leukocytes | Their numbers are elevated, are larger and more granular, express diminished levels of antioxidant genes but elevated levels of pro-apoptotic and pro-inflammatory genes. |
Innate immunity | |
Complement system | Attachment of C-type lectin proteins to mannose residues is decreased, lectin pathway is impaired, CD59 activity is reduced, MAC deposition in vascular walls is increased. |
Dendritic cells (DCs) | Their numbers and activity are reduced. |
Macrophages | Their cholesterol efflux is decreased, generate foam cells, have dysfunctional efferocytosis. |
Neutrophils | Are activated, constitutively release NETs, produce high levels of MPO, ROS, and calprotectin (S100A8/A9), are more susceptible to apoptosis, their migration, phagocytosis and microbial killing are impaired. |
NK cells | Their numbers are increased but are usually dysfunctional, express high levels of GLUT4 but decreased levels of NKG2D and NKp46, have reduced degranulation capacity, are more susceptible to apoptosis. |
NKT cells | Their numbers are increased, produce high levels of IFN-γ, IL-4, and IL-17, express high levels of NKp30, NKG2D, and NKp44 but low levels of NKG2A and 158b. |
Innate lymphoid cells (ILCs) | ILC1s are increased and produce high levels of IFN-γ. |
Adaptive immunity | |
Humoral immunity (B cells) | Germinal centers are reduced, Ab production and isotype switching is defective, Abs become glycated, Abs fail to activate complement. |
Cellular immunity (T-Cells) | Pathogen-specific Th17 cells are decresed, Th1 cells are elevated, have decreased expression of perforin, GrB and CD107a. |
Ab, antibody; GLUT-4, glucose transporter type 4; GrB, granzyme B; IFN, interferon; IL, interleukin; MAC, membrane attack complex; MPO, Myeloperoxidase; NET, neutrophil extracellular traps; NKG2D, the natural killer group 2d; ROS, reactive oxygen species; Th, helper T cell.